You are here
- Home
- Therapy Areas
- Neuroscience
A randomised, parallel group, open trial examining the safety, efficacy and tolerability of fast titration, 800mg/day by day 4, of quetiapine fumarate compared to standard titration, 400mg/day by day 4, in the treatment of Bipolar 1 Manic episode - FATIMA.
- Disease
- schizophrenia
- Drug Name
- Seroquel
- Generic Name
- quetiapine
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IIIb
- Start Date
- Jan 21, 2004
- Study Name
- D1441L00022
- Study Id
- D1441L00022
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
